Related Experiment Video
Updated: Aug 6, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Pulmonary MRI in Interstitial Lung Disease: A Systematic Review and Meta-Analysis
Thiago de Gaultier Paulo1, João Martins da Fonseca2, Liana F Corrêa3
1Department of Radiology, Universidade de São Paulo, São Paulo, SP, Brazil.
Background:
Magnetic resonance imaging (MRI) has emerged as a radiation-free alternative for evaluating interstitial lung disease (ILD), but its diagnostic performance relative to computed tomography (CT) remains variably reported.
Purpose:
To evaluate the diagnostic performance of pulmonary MRI for ILD detection and identification of key imaging hallmarks, using CT as the primary reference standard.
Study Type:
Systematic review and meta-analysis of observational studies.
Population:
Twenty-five studies including 959 participants were included in the qualitative synthesis; nine studies (n = 473) were eligible for quantitative meta-analysis.
Field Strength/Sequence:
MRI field strengths ranged from 0.55 to 3.0 T and included ultrashort echo-time (UTE), zero echo-time (ZTE), T2-weighted fast spin-echo, and gradient-echo-based sequences with slice thickness ranging from 1 to 20 mm.
Assessment:
MRI performance was evaluated against CT for global ILD detection and imaging hallmarks including ground-glass opacities, nodules, traction bronchiectasis, reticulations, and honeycombing.
Statistical Tests:
Pooled sensitivity and specificity were estimated jointly using a bivariate hierarchical model of Reitsma et al.; heterogeneity was assessed with I2 statistics (p < 0.10). Leave-one-out sensitivity analyses were performed.
Results:
Pooled sensitivity was 0.91 (95% CI: 0.84-0.95; I2: 42.1%) and pooled specificity was 0.86 (95% CI: 0.73-0.93; I2: 62.6%) and summary SROC AUC of 0.939. In a predefined subanalysis restricted to UTE/ZTE thin-slice protocols (four studies), sensitivity was 0.93 (95% CI: 0.87-0.97; I2: 0.0%) and specificity was 0.92 (95% CI: 0.78-0.98; I2: 51.3%).
Data Conclusion:
Pulmonary MRI demonstrates high diagnostic performance for ILD detection, with results suggesting protocol-dependent performance and improved consistency under optimized UTE/ZTE thin-slice acquisitions.
Evidence Level:
3.
Technical Efficacy:
Stage 2.
Related Concept Videos
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

